[{"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":5134000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockConvertibleSharesIssuable_0_Q3_shares":49864120.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":50000.0,"OtherNonoperatingExpense_3_Q3_USD":11763000.0,"OtherNonoperatingExpense_1_Q3_USD":114000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":240000.0,"OperatingIncomeLoss_3_Q3_USD":-77221000.0,"OperatingIncomeLoss_1_Q3_USD":-30275000.0,"OperatingExpenses_3_Q3_USD":75351000.0,"OperatingExpenses_1_Q3_USD":30316000.0,"PreferredStockSharesAuthorized_0_Q3_shares":87223095.0,"NotesPayableToBankNoncurrent_0_Q3_USD":10366000.0,"NetIncomeLoss_3_Q3_USD":-88984000.0,"NetIncomeLoss_1_Q3_USD":-30389000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-67026000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-50000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":125308000.0,"LiabilitiesFairValueAdjustment_3_Q3_USD":-2667000.0,"LiabilitiesCurrent_0_Q3_USD":30680000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":134916000.0,"Liabilities_0_Q3_USD":41286000.0,"InterestPayableCurrent_0_Q3_USD":31000.0,"NotesPayableToBankCurrent_0_Q3_USD":425000.0,"InterestExpense_3_Q3_USD":493000.0,"PreferredStockSharesIssued_0_Q3_shares":77588669.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":14299000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":250997000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":70000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":59000.0,"StockholdersEquity_0_Q3_USD":-157367000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":0.32,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3_Q3_shares":15405.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":0.0,"ShareBasedCompensation_3_Q3_USD":5602000.0,"SecurityDeposit_0_Q3_USD":20000.0,"PreferredStockSharesOutstanding_0_Q3_shares":77588669.0,"Revenues_3_Q3_USD":67000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-181290000.0,"RestrictedCashNoncurrent_0_Q3_USD":74000.0,"RestrictedCash_0_Q3_USD":74000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":54221000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":23616000.0,"RepaymentsOfConvertibleDebt_3_Q3_USD":2096000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":11382000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":13086000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":70000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":2000000.0,"Revenues_1_Q3_USD":50000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":68728509000.0,"InterestExpense_1_Q3_USD":109000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-2625000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":79804177.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":2056722.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":58232000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":89449000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":89375000.0,"AssetsFairValueDisclosure_0_Q3_USD":84000000.0,"AssetsCurrent_0_Q3_USD":104054000.0,"Assets_0_Q3_USD":134916000.0,"CommonStockSharesAuthorized_0_Q3_shares":170650960.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":72635150.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":695000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":291000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":5602000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1464000.0,"AdditionalPaidInCapital_0_Q3_USD":23668000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1704000.0,"AccruedSalariesCurrent_0_Q3_USD":2138000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2240000.0,"AccountsPayableRelatedPartiesCurrent_0_Q3_USD":21216000.0,"AccountsPayableCurrent_0_Q3_USD":3905000.0,"AmortizationOfFinancingCosts_3_Q3_USD":50000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":10155000.0,"CommonStockValue_0_Q3_USD":255000.0,"CostOfRevenue_1_Q3_USD":9000.0,"IncreaseDecreaseInDueToRelatedParties_3_Q3_USD":13212000.0,"IncreaseDecreaseInDueFromRelatedParties_3_Q3_USD":18000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":4521000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"GrossProfit_3_Q3_USD":-1870000.0,"GrossProfit_1_Q3_USD":41000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":21130000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6700000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-24000.0,"ConvertibleNotesPayableCurrent_0_Q3_USD":0.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-5000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":214000.0,"EquityFairValueAdjustment_3_Q3_USD":-8365000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.3,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.44,"DueFromRelatedPartiesCurrent_0_Q3_USD":380000.0,"Depreciation_3_Q3_USD":928000.0,"Depreciation_1_Q3_USD":400000.0,"DeferredFinanceCostsCurrentNet_0_Q3_USD":0.0,"DebtConversionConvertedInstrumentAmount1_3_Q3_USD":27379000.0,"CostOfRevenue_3_Q3_USD":1937000.0,"FiniteLivedLicenseAgreementsGross_0_Q3_USD":13217000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":68667682000.0,"Ticker":"VAXX","CIK":"1851657","name":"VAXXINITY, INC.","OfficialName":"Vaxxinity Inc. Class A Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"429117892.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211223"}]